HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

D Anderson Selected Research

D Anderson Research Topics

Disease

10	DNA Damage 03/2007 - 01/2000
7	Neoplasms (Cancer) 01/2003 - 01/2001
6	Infection 04/2007 - 02/2000
4	Chromosome Aberrations (Chromosome Abnormalities) 07/2004 - 08/2000
4	Hemorrhage 06/2001 - 02/2000
3	Pain (Aches) 10/2006 - 02/2000
2	Sarcoma (Soft Tissue Sarcoma) 01/2003 - 01/2000
2	Adenocarcinoma 01/2003 - 01/2000
2	Vomiting 01/2003 - 01/2000
2	Nausea 01/2003 - 01/2000
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2001 - 02/2000
2	Pulmonary Embolism 10/2001 - 02/2000
2	Venous Thromboembolism 10/2001 - 09/2001
2	Iron Overload 01/2000 - 01/2000
1	Myocardial Infarction 10/2006
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2006
1	Multiple Sclerosis 12/2003
1	Myasthenia Gravis 12/2003
1	Carcinoma (Carcinomatosis) 01/2003
1	Viremia 02/2002
1	Reperfusion Injury 01/2002
1	Blister (Bulla) 12/2001
1	Necrosis 12/2001
1	Lung Neoplasms (Lung Cancer) 10/2001
1	Colonic Neoplasms (Colon Cancer) 10/2001
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2001
1	Thromboembolism 09/2001
1	Acne Vulgaris 09/2001
1	Cicatrix (Scar) 09/2001
1	Erythema 09/2001
1	Inflammation 09/2001
1	Pelvic Pain 08/2001
1	Body Weight (Weight, Body) 06/2001
1	Weight Gain 06/2001
1	Shock 06/2001
1	Hemorrhagic Shock 06/2001
1	Hypophosphatemia 03/2001
1	Wasting Syndrome (Wasting Disease) 03/2001
1	X-Linked Dominant Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 03/2001

Drug/Important Bio-Agent (IBA)

6	DNA (Deoxyribonucleic Acid)IBA 07/2004 - 01/2000
3	AlkaliesIBA 01/2007 - 08/2000
3	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2004 - 01/2000
2	Carbon MonoxideIBA 12/2003 - 02/2002
2	MutagensIBA 01/2003 - 01/2001
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 09/2001 - 02/2000
2	Warfarin (Coumadin)FDA LinkGeneric 09/2001 - 02/2000
2	IronIBA 01/2001 - 01/2000
2	OxygenIBA 01/2001 - 02/2000
2	AntibodiesIBA 01/2001 - 01/2000
2	Dietary IronIBA 01/2000 - 01/2000
1	SeleniumIBA 04/2007
1	RNA (Ribonucleic Acid)IBA 04/2007
1	mofezolac (N 22)IBA 03/2007
1	Caffeine (No Doz)FDA LinkGeneric 01/2007
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2006
1	Serotonin (5 Hydroxytryptamine)IBA 10/2006
1	Troponin T (T, Troponin)IBA 10/2006
1	duloxetine (Cymbalta)FDA Link 10/2006
1	Tyrosine (L-Tyrosine)FDA Link 03/2004
1	Melanins (Melanin)IBA 03/2004
1	propylene diquat (PDQ(+))IBA 01/2003
1	Ethyl MethanesulfonateIBA 01/2003
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2003
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2002
1	Propidium (Propidium Iodide)IBA 12/2001
1	Mustard Gas (Sulfur Mustard)IBA 12/2001
1	Proteins (Proteins, Gene)IBA 10/2001
1	ButadienesIBA 10/2001
1	ProdrugsIBA 10/2001
1	Cytosine DeaminaseIBA 10/2001
1	Flucytosine (Ancobon)FDA Link 10/2001
1	Fluorouracil (Carac)FDA LinkGeneric 10/2001
1	uracil phosphoribosyltransferaseIBA 10/2001
1	SmokeIBA 10/2001
1	Styrene (Styrol)IBA 10/2001
1	Oncogene Proteins (Oncogene Protein)IBA 10/2001
1	fibrin fragment D (D-dimer)IBA 10/2001
1	1,3-butadieneIBA 10/2001
1	5-(1-aziridinyl)-2,4-dinitrobenzamideIBA 09/2001
1	Ascorbic Acid (Vitamin C)FDA Link 09/2001
1	Bleomycin (Blenoxane)FDA LinkGeneric 09/2001
1	CholesterolIBA 09/2001
1	CollagenIBA 09/2001
1	OxidoreductasesIBA 09/2001
1	lofexidineIBA 08/2001
1	Complement System Proteins (Complement)IBA 07/2001
1	salicylhydroxamic acid (SHAM)IBA 06/2001
1	Ringer's solutionIBA 06/2001
1	Hetastarch (Pentastarch)FDA Link 06/2001
1	isopreneIBA 06/2001
1	1,25-dihydroxyvitamin DIBA 03/2001

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2003 - 01/2000
3	Chelation Therapy (Therapy, Chelation) 01/2001 - 01/2000
2	Combination Drug Therapy (Combination Chemotherapy) 01/2003 - 01/2000
2	Palliative Care (Palliative Medicine) 01/2003 - 01/2000
2	Aftercare (After-Treatment) 01/2003 - 01/2000
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2002 - 08/2000
1	Heterologous Transplantation (Xenotransplantation) 10/2001
1	Solid-State Lasers 09/2001
1	Resuscitation 06/2001